214 related articles for article (PubMed ID: 3219995)
1. Therapeutic efficacy of ofloxacin, ciprofloxacin and NY-198 in experimentally infected normal and alloxan-induced diabetic mice.
Obana Y; Nishino T
Drugs Exp Clin Res; 1988; 14(5):327-31. PubMed ID: 3219995
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic effect of the quinolone prodrug prulifloxacin against experimental urinary tract infections in mice.
Tomii Y; Ozaki M; Matsuda M; Honmura T; Nishimura I; Yamaguchi R; Adachi T; Okawa Y; Nishino T
Arzneimittelforschung; 1996 Dec; 46(12):1169-73. PubMed ID: 9006794
[TBL] [Abstract][Full Text] [Related]
3. In vivo activity of ciprofloxacin, ofloxacin, norfloxacin and pipemidic acid against Escherichia coli infections in mice.
Obana Y; Nishino T
Drugs Exp Clin Res; 1989; 15(2):53-8. PubMed ID: 2661182
[TBL] [Abstract][Full Text] [Related]
4. Rufloxacin (MF-934): in vitro and in vivo antibacterial activity.
Ravizzola G; Pinsi G; Pirali F; Colombrita D; Foresti I; Peroni L; Turano A
Drugs Exp Clin Res; 1989; 15(1):11-5. PubMed ID: 2743869
[TBL] [Abstract][Full Text] [Related]
5. Criteria for use of ofloxacin and lomefloxacin in adult inpatients and outpatients.
Spivey IM
Clin Pharm; 1993 Jun; 12(6):452-8. PubMed ID: 8403817
[No Abstract] [Full Text] [Related]
6. Activity of ciprofloxacin and levofloxacin in experimental pneumonia caused by Klebsiella pneumoniae deficient in porins, expressing active efflux and producing QnrA1.
Rodríguez-Martínez JM; Pichardo C; García I; Pachón-Ibañez ME; Docobo-Pérez F; Pascual A; Pachón J; Martínez-Martínez L
Clin Microbiol Infect; 2008 Jul; 14(7):691-7. PubMed ID: 18558942
[TBL] [Abstract][Full Text] [Related]
7. [Tavanik effectiveness and safety in the treatment of urinary tract infection complications].
Loran OB; Pushkar' DIu; Rasner PI
Klin Med (Mosk); 2001; 79(12):35-8. PubMed ID: 11840809
[TBL] [Abstract][Full Text] [Related]
8. Clinical efficacy of the new quinolones in lower respiratory infections.
Davies BI; Maesen FP
Chemioterapia; 1987 Jun; 6(2 Suppl):447-8. PubMed ID: 3509469
[No Abstract] [Full Text] [Related]
9. Quinolones for short-term treatment of uncomplicated urinary tract infection.
Kadiri S; Ajayi SO; Toki RA
East Afr Med J; 1999 Oct; 76(10):587-9. PubMed ID: 10734512
[TBL] [Abstract][Full Text] [Related]
10. In vivo evaluation of NM441, a new thiazeto-quinoline derivative.
Ozaki M; Matsuda M; Tomii Y; Kimura K; Segawa J; Kitano M; Kise M; Shibata K; Otsuki M; Nishino T
Antimicrob Agents Chemother; 1991 Dec; 35(12):2496-9. PubMed ID: 1667252
[TBL] [Abstract][Full Text] [Related]
11. [Maxaquin and ciprofloxacin in the treatment of complicated and recurrent urinary infections in adults].
Savitskaia KI; Trapeznikova MF; Nekhorosheva AG; Solodilova OE; Nasonov VN; Dutov VV; Kalinin VN; Shanina AG; Rusanova EV
Klin Med (Mosk); 1994; 72(2):38-42. PubMed ID: 8015241
[TBL] [Abstract][Full Text] [Related]
12. Activity of temafloxacin against respiratory pathogens.
Swanson RN; Hardy DJ; Chu DT; Shipkowitz NL; Clement JJ
Antimicrob Agents Chemother; 1991 Mar; 35(3):423-9. PubMed ID: 2039192
[TBL] [Abstract][Full Text] [Related]
13. The fluoroquinolones after ciprofloxacin and ofloxacin.
Hooper DC
Curr Clin Top Infect Dis; 2000; 20():63-91. PubMed ID: 10943519
[No Abstract] [Full Text] [Related]
14. [Effect of quinolones on mice experimental infection by Plasmodium berghei and their possible therapeutic usefulness].
Amato Neto V; Braz LM; Campos R; Matsubara L; Silva Mde F; Pinto PL
Rev Hosp Clin Fac Med Sao Paulo; 1993; 48(3):116-8. PubMed ID: 8248700
[TBL] [Abstract][Full Text] [Related]
15. [Value of quinolones in the treatment of lower respiratory tract infections caused by intracellular organisms, excluding mycobacteria].
Chidiac C; Senneville E; Mouton Y
Pathol Biol (Paris); 1992 Jun; 40(6):638-45. PubMed ID: 1408383
[TBL] [Abstract][Full Text] [Related]
16. Levofloxacin. Its use in infections of the respiratory tract, skin, soft tissues and urinary tract.
Langtry HD; Lamb HM
Drugs; 1998 Sep; 56(3):487-515. PubMed ID: 9777318
[TBL] [Abstract][Full Text] [Related]
17. [The use of Maxaquin (lomefloxacin hydrochloride) in the treatment of nonspecific inflammatory diseases and in the prevention of surgical interventions in urology].
Derevianko II; Lopatkin NA; Khodyreva LA; Kondrat'eva EM
Urol Nefrol (Mosk); 1998; (5):14-8. PubMed ID: 9820038
[No Abstract] [Full Text] [Related]
18. Quinolone therapy of Klebsiella pneumoniae sepsis following irradiation: comparison of pefloxacin, ciprofloxacin, and ofloxacin.
Brook I; Elliott TB; Ledney GD
Radiat Res; 1990 May; 122(2):215-7. PubMed ID: 2186431
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of quinolones against secondary pneumococcal pneumonia after influenza virus infection in mice.
Hayashi K; Kadowaki SE; Takei M; Fukuda H
Antimicrob Agents Chemother; 2006 Feb; 50(2):748-51. PubMed ID: 16436736
[TBL] [Abstract][Full Text] [Related]
20. [Microbiological evaluation of ciprofloxacin efficacy for treatment of urinary tract infections].
Kalisz J; Denys A; Szczerba W; Rusinek A; Rogowska-Kalisz A
Med Dosw Mikrobiol; 1996; 48(3-4):169-75. PubMed ID: 9182138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
